Skip to content

Making HD Voices Heard

Making HD Voices Heard - A Pilot Study on the myHDstory™ Platform

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05268029
Enrollment
698
Registered
2022-03-07
Start date
2022-03-23
Completion date
2023-10-11
Last updated
2023-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Huntington Disease

Brief summary

The Pilot Study, Making HD Voices Heard, will ask people living with HD to report what they experience and how they function.

Detailed description

The Huntington Study Group (HSG) myHDstory™ Platform is an online, observational research platform that will host the Pilot Study, Making HD Voices Heard. The Pilot Study will ask people living with HD to report what they experience and how they function. Participants will provide self-reported information using their own compatible smartphones, laptops, desktops, or tablets. Participants will be asked to reply to a series of questions, including open-ended questions that will be transcribed by voice (microphone voice-to-text transcription) or keyboard-entered text to record what they experience in their own words.

Interventions

None listed

Sponsors

Huntington Study Group
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults age 18 years and older * Willing and able to provide informed consent electronically. * Individuals answering as a participant must self-report they have been diagnosed with HD by a doctor. * Ability to answer online questions or direct someone else to enter answers for them. * Ability to ambulate independently and take care of some of his or her personal needs. * Ability to read and understand English. * Willing to create a unique identifier based on personal demographic information. * Residing in the United States or its territories * Owning or having access to an electronic device and secure internet connectivity

Exclusion criteria

An individual who does not meet all the inclusion criteria will be excluded from participation in this study.

Design outcomes

Primary

MeasureTime frameDescription
The ability to successfully consent and enroll at least 200 HD participants who have early to mid-stage manifest HD.3 monthsAbility to successfully consent and enroll at least 200 manifest HD participants (independent or with help of assistants) within three months as measured by the number of help line calls or emails received requesting technical or clinical support.
Participants' ability to successfully complete online self-reported questionnaires.3 monthsParticipants' ability to successfully complete online self-reported questionnaires as measured by the number of completed questionnaires.
Utility and informativeness of data collected.9 monthsUtility and informativeness of capturing, extracting, curating, and analyzing verbatim responses to open-ended questions in the form of the HD-Patient Report of Problems (HD-PROP).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026